In What Direction Will Allarity Therapeutics Inc.’s (NASDAQ:ALLR) Stock Goes From Here?

The closing price of Allarity Therapeutics Inc. (NASDAQ: ALLR) was $0.24 for the day, down -18.40% from the previous closing price of $0.29. In other words, the price has decreased by -$0.0541 from its previous closing price. On the day, 7090806 shares were traded. ALLR stock price reached its highest trading level at $0.2750 during the session, while it also had its lowest trading level at $0.2320.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.



Our analysis of ALLR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.50. In the meantime, Its Debt-to-Equity ratio is 0.79 whereas as Long-Term Debt/Eq ratio is at 0.79.

Upgrades & Downgrades

Stock Price History:

Over the past 52 weeks, ALLR has reached a high of $9.67, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 0.3486, while the 200-Day Moving Average is calculated to be 1.1299.

Shares Statistics:

ALLR traded an average of 1.72M shares per day over the past three months and 5.58M shares per day over the past ten days. A total of 9.87M shares are outstanding, with a floating share count of 8.41M. Insiders hold about 10.04% of the company’s shares, while institutions hold 1.70% stake in the company. Shares short for ALLR as of Oct 13, 2022 were 18.67k with a Short Ratio of 0.16M, compared to 117.38k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.18% and a Short% of Float of 0.21%.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.19 and low estimates of -$0.25.

Analysts are recommending an EPS of between -$1.42 and -$1.58 for the fiscal current year, implying an average EPS of -$1.5. EPS for the following year is -$0.73, with 2 analysts recommending between -$0.56 and -$0.91.